Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo
Katja Giersch, Oliver D. Bhadra, Tassilo Volz, et al.
Gut (2017) Vol. 68, Iss. 1, pp. 150-157
Closed Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
Stephan Urban, Christoph Neumann‐Haefelin, Pietro Lampertico
Gut (2021) Vol. 70, Iss. 9, pp. 1782-1794
Open Access | Times Cited: 174
EASL Clinical Practice Guidelines on hepatitis delta virus
Maurizia Rossana Brunetto, G. Ricco, Francesco Negro, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 433-460
Open Access | Times Cited: 129
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial
Heiner Wedemeyer, Katrin Schöneweis, Pavel Bogomolov, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. 117-129
Closed Access | Times Cited: 98
Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies
Lena Allweiss, Annika Volmari, Vithika Suri, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 6, pp. 882-891
Open Access | Times Cited: 18
Hepatitis B virus DNA integration: Implications for diagnostics, therapy, and outcome
Fabien Zoulim, Pei‐Jer Chen, Maura Dandri, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 6, pp. 1087-1099
Open Access | Times Cited: 16
A review on hepatitis D: From virology to new therapies
Nathalie Mentha, Sophie Clément, Francesco Negro, et al.
Journal of Advanced Research (2019) Vol. 17, pp. 3-15
Open Access | Times Cited: 104
Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread
Zhenfeng Zhang, Yi Ni, Florian A. Lempp, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 957-966
Closed Access | Times Cited: 49
The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
Marc Puigvehí, Carlos Moctezuma‐Velázquez, Augusto Villanueva, et al.
JHEP Reports (2019) Vol. 1, Iss. 2, pp. 120-130
Open Access | Times Cited: 66
Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates
Wenshi Wang, Florian A. Lempp, Franziska Schlund, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 2, pp. 311-323
Open Access | Times Cited: 43
A Review of HDV Infection
Gian Paolo Caviglia, Alessia Ciancio, Mario Rizzetto
Viruses (2022) Vol. 14, Iss. 8, pp. 1749-1749
Open Access | Times Cited: 36
Diagnosis and Management of Hepatitis Delta Virus Infection
Calvin Pan, Robert G. Gish, Ira M. Jacobson, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 8, pp. 3237-3248
Open Access | Times Cited: 22
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta
Julius Hollnberger, Yang Liu, Simin Xu, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 3, pp. 657-665
Closed Access | Times Cited: 18
Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections
Thomas Tu, Stephan Urban
Current Opinion in Virology (2018) Vol. 30, pp. 68-79
Closed Access | Times Cited: 58
HBV/HDV Coinfection
Christopher Koh, Ben L. Da, Jeffrey S. Glenn
Clinics in Liver Disease (2019) Vol. 23, Iss. 3, pp. 557-572
Open Access | Times Cited: 51
Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation
Florian A. Lempp, Franziska Schlund, Lisa Rieble, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 48
New insights into HDV persistence: The role of interferon response and implications for upcoming novel therapies
Zhenfeng Zhang, Stephan Urban
Journal of Hepatology (2020) Vol. 74, Iss. 3, pp. 686-699
Open Access | Times Cited: 48
Snake Deltavirus Utilizes Envelope Proteins of Different Viruses To Generate Infectious Particles
Leonóra Szirovicza, Udo Hetzel, Anja Kipar, et al.
mBio (2020) Vol. 11, Iss. 2
Open Access | Times Cited: 44
Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy
Vincent Soriano, Víctor Moreno‐Torres, Ana Treviño, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 155-166
Open Access | Times Cited: 15
Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in HDV RNA
Katja Deterding, Cheng‐Jian Xu, Kerstin Port, et al.
Journal of Viral Hepatitis (2023) Vol. 30, Iss. 7, pp. 597-606
Open Access | Times Cited: 13
Hepatitis D infection: from initial discovery to current investigational therapies
Ben L. Da, Theo Heller, Christopher Koh
Gastroenterology report (2019) Vol. 7, Iss. 4, pp. 231-245
Open Access | Times Cited: 42
Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies
Harish Gopalakrishna, Maria Mironova, Harel Dahari, et al.
Current Hepatology Reports (2024) Vol. 23, Iss. 1, pp. 32-44
Open Access | Times Cited: 4
Exploring Predictive Factors for Bulevirtide Treatment Response in Hepatitis Delta-Positive Patients
Verdiana Zulian, Leonidas Salichos, Chiara Taibi, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 280-280
Open Access
RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response
Teng-Feng Li, Paul Rothhaar, Arthur Lang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Hepatitis D: challenges in the estimation of true prevalence and laboratory diagnosis
Lin-Yuan Chen, Xiao‐Yu Pang, Hemant Goyal, et al.
Gut Pathogens (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 26
Innate immunity in hepatitis B and D virus infection: consequences for viral persistence, inflammation, and T cell recognition
Maura Dandri, Antonio Bertoletti, Marc Lütgehetmann
Seminars in Immunopathology (2021) Vol. 43, Iss. 4, pp. 535-548
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top